Clinical Trial Update: The Effects of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effects of spironolactone on calcineurin inhibitor–induced nephrotoxicity in renal transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorder Related to Renal Transplantation

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Odense University Hospital | Conditions: Disorder Related to Renal Transplantation | Phase 4 | Status: COMPLETED